Abstract
Magnesium is a ubiquitous element in nature and forms an estimated 2.1 % of the earth’s crust. Like calcium, it is an alkali earth metal. Magnesium plays an important role in a wide range of fundamental biological reactions. Magnesium is the second most abundant intracellular cation and the fourth most abundant cation in the body. The normal adult contains about 22–24 g of magnesium [1]. About 60 % of the magnesium is present in the bones, of which 30 % is exchangeable and functions as reservoir to stabilize serum concentration. About 20 % is in skeletal muscles and 19 % in other soft tissues. Skeletal muscle and liver contain between 7 and 9 mmol/kg wet tissue; between 20 % and 30 % of this is relatively exchangeable. Magnesium is principally an intracellular cation, with less than 1 % in the extracellular fluids. Most intracellular magnesium exists in bound form and only 0.25–1 nmol is present as free Mg2+. Free magnesium constitutes only 1–5 % of total cellular magnesium. In normal adults, approximately 20 % of serum magnesium is protein-bound, 65 % is ionized, and the rest is complexed with various anions such as phosphate and citrate [1]. Of the protein-bound fraction, 60–70 % is associated with albumin, and the rest is bound to globulins [2]. Free ionized magnesium is the physiologically active form of the element. The intracellular levels of the free magnesium serve to regulate intermediate metabolism through activation of rate-limiting enzymes such as hexokinase, pyruvate dehydrogenase, enolase, or creatine phosphokinase [3]. In enzymatic reactions magnesium interacts either by binding to the substrate or directly to the enzyme. All of the enzymatic reactions that hydrolyze and transfer enzymatic groups, involving those associated with the reactions involving adenosine triphosphate (ATP), show an absolute requirement for magnesium [4]. There is great volume of research that suggests an association between reduced magnesium intake and insulin resistance, central to type 2 diabetes. It is the purpose of this chapter to associate reduced magnesium intake to type 2 diabetes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Saris NE, Mervaala E, Karppanen H, Khawaja JA, Lewenstam A. Magnesium. An update on physiological, clinical and analytical aspects. Clin Chim Acta. 2000;294:1–26.
Kroll MH, Elin RJ. Relationship between magnesium and protein concentrations in serum. Clin Chem. 1985;31:244–6.
Altura BM, Altura BT. Role of magnesium in patho-physiological processes and the clinical utility of magnesium ion selective electrodes. Scand J Clin Lab Invest Suppl. 1996;224:211–34.
Dresoti E. Magneium status and health. Nutr Rev. 1995;53:S23.
Academy N. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. Washington: National Academy Press; 1997.
Marrier JR. Magnesium content of the food supply in the modern day world. Magnesium. 1986;5:1–8.
Quaranta S, Buscaglia MA, Meroni MG, Colombo E, Cella S. Pilot study of the efficacy and safety of a modified-release magnesium 250 mg tablet (sincromag) for the treatment of premenstrual syndrome. Clin Drug Investig. 2007;27:51–8.
Brink EJ, Beynen AC. Nutrition and magnesium absorption: a review. Prog Food Nutr Sci. 1992;16:125–62.
Quamme GA. Renal magnesium handling: new insights in understanding old problems. Kidney Int. 1997;52:1180–95.
Hardwick LL, Jones MR, Brautbar N, Lee DB. Magnesium absorption: mechanisms and the influence of vitamin D, calcium and phosphate. J Nutr. 1991;121:13–23.
Rude RK. Magnesium deficiency and diabetes mellitus. Causes and effects. Postgrad Med. 1992;92:217–9.
Quamme GA. Control of magnesium transport in the thick ascending limb. Am J Physiol. 1989;256:F197–210.
Lajer H, Daugaard G. Cisplatin and hypomagnesemia. Cancer Treat Rev. 1999;25:47–58.
Rob PM, Lebeau A, Nobiling R, Schmid H, Bley N, Dick K, et al. Magnesium metabolism: basic aspects and implications of cyclosporine toxicity in rats. Nephron. 1996;72:59–66.
Haenni A, Ohrvall M, Lithell H. Serum magnesium status during lipid- lowering drug treatment in non-insulin-dependent diabetic patients. Metabolism. 2001;50:1147–51.
Rivlin RS. Magnesium deficiency and alcohol intake: mechanisms, clinical significance and possible relation to cancer development (a review). J Am Coll Nutr. 1994;13:416–23.
Kruse HD, Orent ER, McCollum EV. Studies on magnesium deficiency in animals – I. Symptomatology resulting from magnesium deprivation. J Biol Chem. 1932;96:519–39.
Hirschfelder AD, Haury VG. Clinical manifestations of high and low plasma magnesium: dangers of Epsom salt purgation in nephritis. JAMA. 1934;102:1138–41.
Wilkinson SR, Stuedemann JA, Grunes DL, Devine OJ. Relation of soil and plant magnesium to nutrition of animals and man. Magnesium. 1987;6:74–90.
Oralewska B, Zawadzki J, Jankowska I, Popinska K, Socha J. Disorders of magnesium homeostasis in the course of liver disease in children. Magnes Res. 1996;9:125–8.
Rude RK. Magnesium disorders. In: Kokko JP, Tannen RL, editors. Fluids and electrolytes. Philadelphia: Saunders; 1996. p. 421–45.
Shils ME. Experimental human magnesium depletion. Medicine. 1969;48:61–85.
Durlach J, Bac P, Durlach V, Bara M, Guiet-Bara A. Neurotic, neuromuscular and autonomic nervous form of magnesium imbalance. Magnes Res. 1997;10:169–95.
Hisakawa N, Yasuoka N, Itoh H, Takao T, Jinnouchi C, Nishiya K, et al. A case of Gitelman’s syndrome with chondrocalcinosis. Endocr J. 1998;45:261–7.
Shils ME. Magnesium. In: Shils ME, Olson JE, Shike M, Ross AC, editors. Modern nutrition in health & disease. Baltimore: Williams & Wilkins; 1998. p. 169–92.
Durlach J, Bac P, Durlach V, Rayssiguier Y, Bara M, Guiet-Bara A. Magnesium status and ageing: an update. Magnes Res. 1998;11:25–42.
Durlach J, Durlach V, Bac P, Rayssiguier Y, Bara M, Guiet-Bara A. Magnesium and ageing. II. Clinical data: aetiological mechanisms and pathophysiological consequences of magnesium deficit in the elderly. Magnes Res. 1993;6:379–94.
Hayes JP, Ryan MF, Brazil N, Riordan TO, Walsh JB, Coakley D. Serum hypomagnesaemia in an elderly day-hospital population. Ir Med J. 1989;82:117–9.
Noronha JL, Matuschak GM. Magnesium in critical illness: metabolism, assessment, and treatment. Intensive Care Med. 2002;28:667–79.
Rubeiz GJ, Thill-Baharozian M, Hardie D, Carlson RW. Association of hypomagnesaemia and mortality in acutely ill medical patients. Crit Care Med. 1993;21:203–9.
Dunn MJ, Walser M. Magnesium depletion in normal man. Metabolism. 1966;15:884–95.
Martindale L, Heaton FW. Magnesium deficiency in the adult rat. Biochem J. 1964;92:119–26.
Alfrey AC, Miller NL, Butkus D. Evaluation of body magnesium stores. J Lab Clin Med. 1974;84:153–62.
Pham PC, Pham PM, Pham SV, Miller JM, Pham PT. Hypomagnesemia in patients with type 2 diabetes. Clin J Am Soc Nephrol. 2007;2:366–73.
Elin RJ, Armstrong WD, Singer L. Body fluid electrolyte composition of chronically magnesium-deficient and control rats. Am J Physiol. 1971;220:543–8.
Elin RJ. Laboratory tests for the assessment of magnesium status in humans. Magnes Trace Elem. 1991;10:172–81.
Avioli LV, Berman M. Mg28 Kinetics in man. J Appl Physiol. 1966;21:1688–94.
Kobrin SM, Goldfarb S. Magnesium deficiency. Semin Nephrol. 1990;10:525–35.
Paolisso G, Sgambato S, Gambardella A, Pizza G, Tesauro P, Varricchio M, et al. Daily magnesium supplements improve glucose handling in elderly subjects. Am J Clin Nutr. 1992;55:1161–7.
Martin HE, Smith K, Wilson ML. Fluid and electrolyte therapy of severe diabetic acidosis and ketosis – study of 29 episodes (26 patients). Am J Med. 1958;24:376–89.
Jackson CE, Meier DW. Routine serum magnesium analysis. Correlation with clinical state in 5,100 patients. Ann Intern Med. 1968;69:743–8.
Lopez-Ridaura R, Willett WC, Rimm EB, Liu S, Stampfer MJ, Manson JE, et al. Magnesium intake and risk of type 2 diabetes in men and women. Diabetes Care. 2004;27:270–1.
Meyer KA, Kushi LH, Jacobs Jr DR, Slavin J, Sellers TA, Folsom AR. Carbohydrates, dietary fiber, and incident type 2 diabetes in older women. Am J Clin Nutr. 2000;71:921–30.
Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL, Brancati FL. Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the atherosclerosis risk in communities study. Arch Intern Med. 1999;159:2151–9.
Longstreet DA, Heath DL, Panaretto KS, Vink R. Correlations suggest low magnesium may lead to higher rates of type 2 diabetes in indigenous Australians. Rural Remote Health. 2007;7:843.
Elin RJ. Magnesium metabolism in health and disease. Dis Mon. 1988;34:161–218.
Styler L. Biochemistry. 3rd ed. New York: Freeman & Co; 1988.
Tongyai S, Rayssiguier Y, Motta C, Gueux E, Maurois P, Heaton FW. Mechanism of increased erythrocyte membrane fluidity during magnesium deficiency in weanling rats. Am J Physiol. 1989;257:C270–6.
Caro JF, Triester S, Patel VK, Tapscott EB, Frazier NL, Dohm GL. Liver glucokinase: decreased activity in patients with type II diabetes. Horm Metab Res. 1995;27:19–22.
Tosiello L. Hypomagnesemia and diabetes mellitus. A review of clinical implications. Arch Intern Med. 1996;156:1143–8.
Chaudhary DP, Boparai RK, Sharma R, Bansal DD. Studies on the development of an insulin resistance rat model by chronic feeding of high sucrose low magnesium diet. Magnes Res. 2004;17:293–300.
Chaudhary DP, Boparai RK, Bansal DD. Effect of low magnesium diet on in-vitro glucose uptake in sucrose fed rats. Magnes Res. 2007;20:187–95.
Hwang IS, Ho H, Hoffman BB, Reaven GM. Fructose induced insulin resistance and hypertension in rats. Hypertension. 1987;10:512–6.
Zavaroni I, Sander S, Scott S, Reaven GM. Effect of fructose feeding on insuin secretion and insulin action in the rats. Metabolism. 1980;29:970–3.
Balon TW, Jasman A, Scott S, Meehan WP, Rude RK, Nadler JL. Dietary magnesium prevents fructose induced insulin insenstivity in rats. Hypertension. 1994;23:1036–9.
Lima ML, Cruz T, Rodrigues LE, Bomfim O, Melo J, Correia R, et al. Serum and intracellular magnesium deficiency in patients with metabolic syndrome–evidences for its relation to insulin resistance. Diabetes Res Clin Pract. 2009;83:257–62.
Evangelopoulos AA, Vallianou NG, Panagiotakos DB, Georgiou A, Zacharias GA, Alevra AN, et al. An inverse relationship between cumulating components of the metabolic syndrome and serum magnesium levels. Nutr Res. 2008;28:659–63.
Seyoum B, Siraj ES, Saenz C, Abdulkadir J. Hypomagnesemia in Ethiopians with diabetes mellitus. Ethn Dis. 2008;18:147–51.
Kandeel FR, Balon E, Scott S, Nadler JL. Magnesium deficiency and glucose metabolism in rat adipocytes. Metabolism. 1996;45:838–43.
Paolisso G, Scheen A, Cozzolino D, Maro GD, Varricchio M, D’Onofrio F, et al. Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type II) diabetic patients. J Clin Endocrinol Metab. 1994;78:1510–4.
Sjögren A, Florén CH, Nilsson A. Oral administration of magnesium hydroxide to subjects with insulin-dependent diabetes mellitus: effects on magnesium and potassium levels and on insulin requirements. Magnesium. 1988;7:117–22.
Olatunji LA, Oyeyipo IP, Micheal OS, Soladoye AO. Effect of dietary magnesium on glucose tolerance and plasma lipid during oral contraceptive administration in female rats. Afr J Med Sci. 2008;37:135–9.
McKeown NM, Jacques PF, Zhang XL, Juan W, Sahyoun NR. Dietary magnesium intake is related to metabolic syndrome in older Americans. Eur J Nutr. 2008;47:210–6.
Guerrero-Romero F, Rascón-Pacheco RA, Rodríguez-Morán M, de la Peña JE, Wacher N. Hypomagnesaemia and risk for metabolic glucose disorders: a 10-year follow-up study. Eur J Clin Invest. 2008;38:389–96.
Schulze MB, Schulz M, Heidemann C, Schienkiewitz A, Hoffmann K, Boeing H. Fiber and magnesium intake and incidence of type 2 diabetes. Arch Intern Med. 2007;167:956–65.
Villegas R, Yang G, Gao Y, Cai H, Li H, Zheng W, et al. Dietary patterns are associated with lower incidence of type 2 diabetes in middle- aged women: the shanghai women’s health study. Int J Epidemiol. 2010;39:889–99.
Fox C, Ramsoomair D, Carter C. Magnesium: its proven and potential clinical significance. South Med J. 2001;94:1195–201.
Nadler JL, Rude RK. Disorders of magnesium metabolism. Endocrinol Metab Clin North Am. 1995;24:623–41.
Nozue T, Kobayashi A, Uemasu F, Takagi Y, Sako A, Endoh H. Magnesium status, serum HDL cholesterol, and apolipoprotein a-1 levels. J Pediatr Gastroenterol Nutr. 1995;20:316–8.
Seelig MS, Heggtveit A. Magnesium interrelationships in ischemic heart disease: a review. Am J Clin Nutr. 1974;27:59–79.
Mather HM, Levin GE, Nisbet JA, Hadley LA, Oakley NM, Pilkington TR. Diurnal profiles of plasma magnesium and blood glucose in diabetes. Diabetologia. 1982;22:180–3.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Chaudhary, D.P. (2013). Magnesium Deficiency in Type 2 Diabetes. In: Watson, R., Preedy, V., Zibadi, S. (eds) Magnesium in Human Health and Disease. Nutrition and Health. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-044-1_7
Download citation
DOI: https://doi.org/10.1007/978-1-62703-044-1_7
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-043-4
Online ISBN: 978-1-62703-044-1
eBook Packages: MedicineMedicine (R0)